FI964095A0 - Intranasaalinen migreeninvastainen koostumus - Google Patents

Intranasaalinen migreeninvastainen koostumus

Info

Publication number
FI964095A0
FI964095A0 FI964095A FI964095A FI964095A0 FI 964095 A0 FI964095 A0 FI 964095A0 FI 964095 A FI964095 A FI 964095A FI 964095 A FI964095 A FI 964095A FI 964095 A0 FI964095 A0 FI 964095A0
Authority
FI
Finland
Prior art keywords
composition
migraine
intranasal
intranasal anti
spray device
Prior art date
Application number
FI964095A
Other languages
English (en)
Swedish (sv)
Other versions
FI964095A (fi
FI118295B (fi
Inventor
Marc Karel Jozef Francois
Roger Carolus August Embrechts
Lisbeth Illum
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI964095A publication Critical patent/FI964095A/fi
Publication of FI964095A0 publication Critical patent/FI964095A0/fi
Application granted granted Critical
Publication of FI118295B publication Critical patent/FI118295B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI964095A 1994-04-13 1996-10-11 Intranasaalinen migreeninvastainen koostumus FI118295B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94200998 1994-04-13
EP94200998 1994-04-13
EP9501302 1995-04-10
PCT/EP1995/001302 WO1995028158A1 (en) 1994-04-13 1995-04-10 Intranasal antimigraine composition

Publications (3)

Publication Number Publication Date
FI964095A FI964095A (fi) 1996-10-11
FI964095A0 true FI964095A0 (fi) 1996-10-11
FI118295B FI118295B (fi) 2007-09-28

Family

ID=8216793

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964095A FI118295B (fi) 1994-04-13 1996-10-11 Intranasaalinen migreeninvastainen koostumus

Country Status (23)

Country Link
EP (1) EP0755253B1 (fi)
JP (1) JP2921988B2 (fi)
KR (1) KR100219952B1 (fi)
CN (1) CN1146151A (fi)
AT (1) ATE194915T1 (fi)
AU (1) AU684360B2 (fi)
BG (1) BG62197B1 (fi)
BR (1) BR9507369A (fi)
CA (1) CA2184822C (fi)
CZ (1) CZ286610B6 (fi)
DE (1) DE69518149T2 (fi)
FI (1) FI118295B (fi)
HR (1) HRP950149A2 (fi)
HU (1) HU219495B (fi)
IL (1) IL113341A (fi)
NO (1) NO310276B1 (fi)
NZ (1) NZ284454A (fi)
PL (1) PL179761B1 (fi)
RO (1) RO115414B1 (fi)
SI (1) SI9500121A (fi)
SK (1) SK129896A3 (fi)
WO (1) WO1995028158A1 (fi)
ZA (1) ZA953038B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
JPH0656675A (ja) * 1992-08-07 1994-03-01 Nippon Soda Co Ltd 家畜の乳房炎予防剤

Also Published As

Publication number Publication date
ATE194915T1 (de) 2000-08-15
JP2921988B2 (ja) 1999-07-19
HU9602806D0 (en) 1996-11-28
WO1995028158A1 (en) 1995-10-26
AU2305495A (en) 1995-11-10
CA2184822C (en) 2000-12-19
RO115414B1 (ro) 2000-02-28
JPH09505606A (ja) 1997-06-03
CZ286610B6 (cs) 2000-05-17
NO310276B1 (no) 2001-06-18
SI9500121A (en) 1995-10-31
HU219495B (hu) 2001-04-28
SK129896A3 (en) 1997-05-07
EP0755253A1 (en) 1997-01-29
NO964333D0 (no) 1996-10-11
FI964095A (fi) 1996-10-11
KR100219952B1 (ko) 1999-09-01
HRP950149A2 (en) 1997-06-30
NO964333L (no) 1996-10-11
PL179761B1 (pl) 2000-10-31
DE69518149D1 (de) 2000-08-31
IL113341A (en) 2000-08-31
PL316756A1 (en) 1997-02-03
CN1146151A (zh) 1997-03-26
HUT75939A (en) 1997-05-28
FI118295B (fi) 2007-09-28
BR9507369A (pt) 1997-09-23
EP0755253B1 (en) 2000-07-26
ZA953038B (en) 1996-10-14
CZ292096A3 (en) 1997-02-12
IL113341A0 (en) 1995-07-31
AU684360B2 (en) 1997-12-11
BG100889A (en) 1997-07-31
BG62197B1 (bg) 1999-05-31
CA2184822A1 (en) 1995-10-26
NZ284454A (en) 1997-12-19
DE69518149T2 (de) 2001-03-22

Similar Documents

Publication Publication Date Title
MY113733A (en) Salts of an anti-migraine indole derivative
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
IL129068A0 (en) Sulfinic acid derivatives and their preparation and use
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
FI964095A (fi) Intranasaalinen migreeninvastainen koostumus
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
ATE493112T1 (de) Nasensalbe auf basis von vaselin
IL126199A0 (en) Nasal pharmaceutical composition for the treatment of delayed emesis
MX9604690A (es) Composicion antimigraña intranasal.
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
MX9701764A (es) Derivados de imidoacidos.
BR9914532A (pt) Processo de preparação de uma solução para pulverização nasal que contém um ou vários hormÈnios sexuais e uma ciclodextrina
ES2170377T3 (es) Composicion que contiene quitosana.
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
ES8601691A1 (es) Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo
TW366338B (en) Arylalkoxyphenoxy-imidazoline compounds
MX9702486A (es) La fabricacion de levobupivacaina y sus analogos de l-lisina.
TW327124B (en) Aikoxy-alkyl-substituted 1H-3-aryl-pyrrolidine-2,4-diones used as pesticides and herbicides
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments
EP0687670A4 (en) OPTICALLY ACTIVE FLUBROCYTHRINATE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118295

Country of ref document: FI

MA Patent expired